Veradermics, Incorporated
- MANE
- NYSE
- Biotechnology
- Dermatology Therapeutics
- Hair Loss Treatment
$122.28
Today +12.37%Quote Oct 19, 2026, 08:00 PM UTC
+14.55%over the last month
Max drawdown −16.9%From 1-month high −6.6%3 months +11.7%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Veradermics
Veradermics, Incorporated functions as a biopharmaceutical enterprise focused on devising pioneering therapeutic interventions for various skin and cosmetic disorders. The company's development pipeline includes treatments for Pattern Hair Loss (PHL), impacting both adult and pediatric demographics.
Sector
Healthcare
Industry
Biotechnology
Exchange
NYSE
Employees
37
Founded
2019
Market value
$5.11B
Quote Oct 19
Floor
$117.68
3.8% below price
Resistance
$123.95
1.4% above price
Price vs analyst targets
5 analysts
Lowest target
$136.00Highest target
$182.00
$136.00Highest target
$182.00
- Price $122.28
- Average target $162.67
- Analysts' target range
The price is below even the lowest analyst target. Analysts' average target sits about 33% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about MANEPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free